Not exact matches
While both the ketogenic and modified high - fat, low - carbohydrate diets showed similar effectiveness
against tumors in the mouse
models, Reynolds said the latter is more nutritionally complete and potentially more appealing to cancer patients because it offers more food choices.
The mouse
model could also contribute to the further development of immunotherapies — a method in which the body's immune system is stimulated, so that it intensifies its fight
against tumor cells.
In their report that has received advance online publication in Nature Nanotechnology, a research team based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic therapy — the use of light to trigger a chemical reaction — with a molecular therapy drug targeted
against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular therapy drug required to suppress
tumor progression and metastatic outgrowth in an animal
model.
«Novel imaging
model helps reveal new therapeutic target for pancreatic cancer: Antisense treatment in preclinical
models shows effectiveness
against deadly
tumors.»
In a 1988 paper summarizing his findings, Fiebig concluded that xenograft mice were wonderful
models for broadly testing new drugs
against human
tumors, but they «can not be used as a clinical routine method» for predicting patient treatment.1 The idea of using xenograft mice as personal avatars for cancer patients was discarded.
James P. Allison and Matthew Krummel demonstrate that a monoclonal antibody directed
against the CTLA - 4 molecule in a mouse
model of melanoma could result in the rejection of
tumors and that this rejection also resulted in immunity to a second exposure to
tumor cells.
We are advancing the fight
against these rare
tumors by developing biological
models to help with drug development and to share with scientists worldwide.
Their work encompasses several strategies, including: developing FL - HCC animal
models to characterize
tumor - immune interactions, exploring if a mutated protein associated with FL - HCC could be targeted by immunotherapy, identifying immune checkpoints that could potentially serve as targets for immunotherapy as well as biomarkers for analyzing patients, and evaluating the effectiveness of immunotherapy strategies
against FL - HCC patient samples in the lab.
Dogs are also helping advance the fight
against human cancer as they serve as a
model for various human
tumors.